Ignite Creation Date:
2024-05-06 @ 4:02 PM
Last Modification Date:
2024-10-26 @ 2:02 PM
Study NCT ID:
NCT04842513
Status:
RECRUITING
Last Update Posted:
2023-12-05
First Post:
2021-03-01
Brief Title:
Multi Peptide Vaccination With XS15 in Addition to Standard Postoperative Radiation Therapy and Temozolomide Chemotherapy in Newly Diagnosed Glioblastoma
Sponsor:
University Hospital Tuebingen
Organization:
University Hospital Tuebingen
Organization Data
Organization:
University Hospital Tuebingen
Class:
OTHER
Study ID:
2020-003357-30
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University Hospital Tuebingen
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None